Company / Shareholders' Equity
CHINA PHARMA HOLDINGS, INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$22.7M
FY2025
5-year range
$4.3M / $22.7M
FY2021-FY2025
Trend
+205.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +205% YoY in FY2025, a notable deviation from the 9-year average annual change of +8%.
Based on SEC 10-K filings.
$23M in FY2025 with a 5-year CAGR of +19.7%.
Improved from $7M to $23M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +74.4%
- 5-Year CAGR
- +19.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +19.7%, indicating consistent growth.
- In FY2025, shareholders' equity increased 205.0% year-over-year.
- Peak shareholders' equity was recorded in FY2016.
- Lowest shareholders' equity in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.7M | +205.0% |
| FY2024 | $7.5M | +0.0% |
| FY2023 | $7.5M | +73.8% |
| FY2022 | $4.3M | -46.4% |
| FY2021 | $8.0M | -13.3% |
| FY2020 | $9.2M | -69.4% |
| FY2019 | $30.2M | -29.9% |
| FY2018 | $43.1M | -26.9% |
| FY2017 | $58.9M | -18.9% |
| FY2016 | $72.6M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026